Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MultiHance”

41 trials

Showing 20 of 41 results

Large-scale testing (Phase 3)Study completedNCT00185276
What this trial is testing

Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries

Who this might be right for
Peripheral Vascular Disease
Bayer 365
Post-approval studies (Phase 4)Study completedNCT02070380
What this trial is testing

Crossover Comparison of MultiHance and Dotarem

Who this might be right for
Brain Disease
Bracco Diagnostics, Inc 179
Large-scale testing (Phase 3)Ended earlyNCT00323310
What this trial is testing

Safety and Efficacy of MultiHance in Pediatric Patients

Who this might be right for
Central Nervous System Diseases
Bracco Diagnostics, Inc 92
Large-scale testing (Phase 3)Study completedNCT00937391
What this trial is testing

Contrast-enhanced MRI in Children 2 Months to <2 Years

Who this might be right for
Magnetic Resonance Imaging
Bayer 54
Not applicableStudy completedNCT02291822
What this trial is testing

Retrospective Study of MRI in Pediatric Patients

Who this might be right for
Central Nervous System DiseaseCentral Nervous System Neoplasms
Bracco Diagnostics, Inc 90
Not applicableUnknownNCT02992847
What this trial is testing

Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)

Who this might be right for
Multiple Sclerosis
Hospices Civils de Lyon 160
Large-scale testing (Phase 3)Study completedNCT00415805
What this trial is testing

Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent

Who this might be right for
Steno-occlusive Disease
Bracco Diagnostics, Inc 39
Not applicableStudy completedNCT00600951
What this trial is testing

Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease

Who this might be right for
Renal Insufficiency
Bracco Diagnostics, Inc 366
Post-approval studies (Phase 4)Ended earlyNCT04973007
What this trial is testing

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

Who this might be right for
Oligometastatic DiseaseLiver MetastasesColorectal Cancer
University of Colorado, Denver 10
Large-scale testing (Phase 3)Study completedNCT01260636
What this trial is testing

Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries

Who this might be right for
Carotid, Aortic, Renal or Peripheral Artery Disease
Bracco Diagnostics, Inc 120
Not applicableStudy completedNCT00539253
What this trial is testing

Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.

Who this might be right for
Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45
Large-scale testing (Phase 3)Study completedNCT00486473
What this trial is testing

Multihance Versus Magnevist in Breast MRI

Who this might be right for
Breast Cancer
Bracco Diagnostics, Inc 130
Large-scale testing (Phase 3)Study completedNCT00408083
What this trial is testing

Crossover Study With MultiHance vs a Comparator for Peripheral MRA

Who this might be right for
Peripheral Vascular Disease
Bracco Diagnostics, Inc 100
Post-approval studies (Phase 4)Study completedNCT00395863
What this trial is testing

Multihance at 3 Tesla (3T) in Brain Tumors

Who this might be right for
Brain Tumor
Bracco Diagnostics, Inc 46
Large-scale testing (Phase 3)Study completedNCT00395733
What this trial is testing

Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients

Who this might be right for
Vascular Diseases
Bayer 83
Large-scale testing (Phase 3)Study completedNCT01211873
What this trial is testing

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

Who this might be right for
Diagnostic Self EvaluationCentral Nervous System Diseases
Guerbet 416
Not applicableStudy completedNCT00744939
What this trial is testing

Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist

Who this might be right for
FibrosisKidney FailureRenal Insufficiency
Bayer 168
Early research (Phase 1)Study completedNCT00310596
What this trial is testing

Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects

Who this might be right for
Healthy
Bayer 71
Large-scale testing (Phase 3)Study completedNCT00395460
What this trial is testing

Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients

Who this might be right for
Central Nervous System Diseases
Bayer 147
Not applicableStudy completedNCT03108378
What this trial is testing

Evaluation of Gd Retention in Human Bone and Skin After MultiHance or ProHance Administration Compared With Control

Who this might be right for
Gadolinium Retention
Bracco Diagnostics, Inc 28
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation